From 2022 to 2023, median total compensation for registered nurses fell 3.32%, though nurses still saw compensation increase over the past decade, according to a June 26 report from the Medical Group Management Association.
Category: Static
Executives' playbook to beat impostor syndrome
Many healthcare executives have faced impostor syndrome during their careers and have learned how to overcome it.
Top 10 digital health deals of Q1
Venture capital funding for digital health appears to have stabilized, though investors are steering clear of struggling sectors like digital therapeutics and telehealth, PitchBook reported.
Former New York hospital CEO dies
Paul Griner, MD, who served as CEO of Strong Memorial Hospital in Rochester, N.Y., for more than a decade, has died, according to a post on the University of Rochester Medical Center website.
UConn Health revenue to top $1B in 2025 — a 133% increase over 10 years
Farmington, Conn.-based UConn Health expects to hit more than $1 billion in patient care revenue in fiscal year 2025,
Why a 'federal north star' is needed for Medicare Advantage prior authorization
Every year it feels like it’s getting harder and harder to work with Medicare Advantage plans, Essentia Health’s senior vice president of revenue services, Melanie Wilson, told Becker’s.
Pennsylvania system loses bid to keep residency program
Upland, Pa.-based Crozer Health lost its bid to keep its general surgery residency program, The Philadelphia Inquirer reported June 26.
All 71 CHS hospitals to use Mark Cuban's drug wholesale services
Mark Cuban Cost Plus Drug Co. will serve as a wholesale drug distributor for all 71 hospitals affiliated with Community Health Systems, the organizations announced June 27.
The 'piecemeal approaches' no longer working for health system finance leaders
Ninety-six percent of CFOs surveyed by Black Book Research said digital transformation efforts remain at the forefront of their health systems’ financial strategy and operations for 2025-2026.
CDC recommends RSV vaccines for all adults over 75
Respiratory syncytial virus vaccinations are now recommended for all adults over age 75 and for high-risk adults between ages 60 and 74, the CDC announced June 26.
